Filing
April 27, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, DC 20549-3720
Attention: Tim Buchmiller
Re: | Savara Inc. |
Registration Statement on Form S-3 |
File No. 333-237734 |
Acceleration Request |
Requested Date: April 29, 2020 |
Requested Time: 4:00 P.M. Eastern Time |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Savara Inc. (the Company) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-237734) (the Registration Statement) be declared effective at the Requested Date and Requested Time set forth above, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Rob Suffoletta at (512) 338-5439 or via email at rsuffoletta@wsgr.com.
[Signature page follows]
Securities and Exchange Commission
April 27, 2020
Page 2
Sincerely,
SAVARA INC.
/s/ Robert Neville
Robert Neville
Chief Executive Officer
cc: | Dave Lowrance, Savara Inc. |
Kate McCabe, Savara Inc. |
J. Robert Suffoletta, Wilson Sonsini Goodrich & Rosati, P.C. |